SAM
TDOC icon

Shell Asset Management’s Teladoc Health TDOC Stock Holding History

Shell Asset Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12K Sell
1,499
-2,894
-66% -$22.6K ﹤0.01% 1099
2025
Q2 		$38K Sell
4,393
-446
-9% -$3.23K ﹤0.01% 1183
2025
Q1 		$39K Sell
4,839
-1,149
-19% -$11.6K ﹤0.01% 1186
2024
Q4 		$54K Hold
5,988
– – ﹤0.01% 1165
2024
Q3 		$55K Buy
+5,988
New +$49.6K ﹤0.01% 1165
2024
Q1 		$48K Sell
4,915
-567
-10% -$10.3K ﹤0.01% 1167
2023
Q4 		$118K Buy
+5,482
New +$101K 0.01% 1016
2022
Q4 		– Sell
-9,851
Closed -$250K – 1402
2022
Q3 		$250K Sell
9,851
-2,286
-19% -$80.2K 0.01% 920
2022
Q2 		$403K Sell
12,137
-281
-2% -$11.9K 0.01% 828
2022
Q1 		$896K Buy
12,418
+423
+4% +$30.5K 0.02% 525
2021
Q4 		$1.1M Sell
11,995
-1,793
-13% -$214K 0.02% 524
2021
Q3 		$1.75M Sell
13,788
-5,739
-29% -$836K 0.04% 361
2021
Q2 		$3.25M Buy
19,527
+8,851
+83% +$1.43M 0.06% 280
2021
Q1 		$1.94M Buy
10,676
+473
+5% +$110K 0.04% 362
2020
Q4 		$2.04M Buy
10,203
+3,290
+48% +$669K 0.04% 378
2020
Q3 		$1.52M Hold
6,913
– – 0.04% 380
2020
Q2 		$1.32M Sell
6,913
-541
-7% -$94.8K 0.03% 381
2020
Q1 		$1.16M Sell
7,454
-5,117
-41% -$595K 0.03% 393
2019
Q4 		$1.05M Buy
12,571
+2,077
+20% +$158K 0.02% 536
2019
Q3 		$711K Hold
10,494
– – 0.02% 706
2019
Q2 		$697K Hold
10,494
– – 0.02% 742
2019
Q1 		$583K Buy
10,494
+3,497
+50% +$213K 0.01% 839
2018
Q4 		$347K Sell
6,997
-6,998
-50% -$428K 0.01% 954
2018
Q3 		$1.21M Sell
13,995
-1,568
-10% -$112K 0.02% 567
2018
Q2 		$903K Sell
15,563
-3,792
-20% -$185K 0.02% 724
2018
Q1 		$780K Hold
19,355
– – 0.02% 771
2017
Q4 		$675K Buy
19,355
+7,009
+57% +$233K 0.01% 812
2017
Q3 		$409K Buy
+12,346
New +$405K 0.01% 921

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Shell Asset Management's TDOC Position: Q3 2025 in Review

Shell Asset Management reduced its Teladoc Health (TDOC) stake by 66% in Q3 2025, selling an estimated $22.6K and leaving 1,499 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Shell Asset Management first reported a position in TDOC in Q3 2017 and has held it in 28 quarters since. The position peaked at $3.25M in Q2 2021. 356 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.

  • Shell Asset Management held 1,499 shares of Teladoc Health worth $12K as of Q3 2025.
  • Shell Asset Management sold 2,894 Teladoc Health shares in Q3 2025, an estimated $22.6K.
  • Teladoc Health made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1099 holding.
  • Shell Asset Management first reported a position in Teladoc Health in Q3 2017 and has held it in 28 quarters since.
  • Shell Asset Management's Teladoc Health position peaked at $3.25M in Q2 2021.
  • 356 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.